Thomas Casale

1. Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
   2013/02/24 by Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh +13 · 33 citations
   Medicine · Immunology and Microbiology · #Urticaria and Related Conditions #Mast cells and histamine #Coagulation, Bradykinin, Polyphosphates, and Angioedema
2. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
   2017/06/08 by Jan L. Brożek, Jan Brożek, Jean Bousquet +79 · 10 citations
   Medicine · #Allergic Rhinitis and Sensitization #Occupational exposure and asthma #Asthma and respiratory diseases
3. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
   2020/02/24 by Ioana Agache, Jessica Beltran, Cezmi Akdis +31 · 1 citation
4. Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009
   2009/12/01 by G Walter Canonica, Jean Bousquet, Thomas Casale +54 · 1 citation
   Medicine · #Allergic Rhinitis and Sensitization #Asthma and respiratory diseases #Otitis Media and Relapsing Polychondritis